Syneron receives US FDA clearance to market UltraShape for fat cell destruction
Syneron Medical Ltd. (NASDAQ: ELOS) has announced that it has received the United States Food and Drug Administration (FDA) 510(k) clearance to...
Read MoreTag: Syneron
From clinic to home: hair removal procedures maintain popularity
Rosalind Hill reviews some of the hair removal devices on the market and speaks to industry experts about the increasing popularity of at-home beauty devices
Read MoreSyneron-Candela launches the VelaShape III
Syneron-Candela has launched the fourth generation of its VelaShape device, the VelaShape III. The device, which has been launch simultaneously...
Read MoreVelaShape® III: mastering the art of body treatments
Industry experts share their thoughts on Syneron’s new VelaShape III device for non-invasive body shaping, including achieving maximum results and the benefits of pulse stacking
Read More
Sep/Oct Issue
